BLUEPRINT MEDICINES CORPORATION Shareholders' Equity
BLUEPRINT MEDICINES CORPORATION had Shareholders' Equity of $342.13 million as of 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-05-01
- 2025-03-31: Stockholders' Equity Attributable to Parent $342.13M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $298.67M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $313.15M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $320.24M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-03-31 | $342.13M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $298.67M 10-Q · filed 2025-05-01 | |
| 2024-09-30 | $313.15M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $320.24M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $310.69M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $130.61M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $202.61M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $311.13M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $414.30M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $514.68M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $640.31M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $747.75M 10-Q · filed 2022-11-01 | |
| 2022-03-31 | $881.67M 10-Q · filed 2022-11-01 | |
| 2021-12-31 | $970.74M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $1.25B 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $1.33B 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $1.40B 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $1.47B 10-Q · filed 2022-11-01 | |
| 2020-09-30 | $1.32B 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $581.37M 10-Q · filed 2021-10-28 | |
| 2020-03-31 | $682.93M 10-Q · filed 2021-10-28 | $682.93M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $464.36M 10-K · filed 2022-02-17 | |
| 2019-09-30 | $516.34M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $592.83M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $344.21M 10-Q · filed 2020-10-29 | |
| 2018-12-31 | $419.01M 10-K · filed 2022-02-17 | |
| 2018-09-30 | $489.30M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $552.93M 10-Q · filed 2019-11-05 | $552.93M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $570.87M 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $623.97M 10-K · filed 2021-02-17 | |
| 2017-09-30 | $341.24M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $374.09M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $188.22M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $213.08M 10-K · filed 2020-02-13 | |
| 2016-09-30 | $97.71M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $112.56M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $129.66M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $143.98M 10-K · filed 2019-02-26 | |
| 2015-09-30 | $158.14M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $169.59M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$90.08M 10-Q · filed 2015-06-11 | |
| 2014-12-31 | -$79.38M 10-K · filed 2018-02-21 | |
| 2013-12-31 | -$41.45M 10-K · filed 2017-03-09 | |
| 2012-12-31 | -$20.92M 10-K · filed 2016-03-11 |